Copyright Reports & Markets. All rights reserved.

Global Dry Eye Disease Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Dry Eye Disease Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Artificial Tears
      • 2.1.2 Secretagogue
      • 2.1.3 Punctal Plugs
      • 2.1.4 Anti-inflammatory
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Artificial Tears
      • 2.2.2 Secretagogue
      • 2.2.3 Punctal Plugs
      • 2.2.4 Anti-inflammatory

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Pharmacies
      • 3.1.2 Independent Pharmacies & Drug Stores
      • 3.1.3 Online pharmacies

    4 Manufacturers Profiles/Analysis

    • 4.1 Santen Pharmaceutical Co., Ltd.
      • 4.1.1 Santen Pharmaceutical Co., Ltd. Profiles
      • 4.1.2 Santen Pharmaceutical Co., Ltd. Product Information
      • 4.1.3 Santen Pharmaceutical Co., Ltd. Dry Eye Disease Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Santen Pharmaceutical Co., Ltd. SWOT Analysis
    • 4.2 Novartis AG
      • 4.2.1 Novartis AG Profiles
      • 4.2.2 Novartis AG Product Information
      • 4.2.3 Novartis AG Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Novartis AG SWOT Analysis
    • 4.3 Johnson & Johnson
      • 4.3.1 Johnson & Johnson Profiles
      • 4.3.2 Johnson & Johnson Product Information
      • 4.3.3 Johnson & Johnson Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Johnson & Johnson SWOT Analysis
    • 4.4 Valeant Pharmaceuticals International, Inc.
      • 4.4.1 Valeant Pharmaceuticals International, Inc. Profiles
      • 4.4.2 Valeant Pharmaceuticals International, Inc. Product Information
      • 4.4.3 Valeant Pharmaceuticals International, Inc. Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Valeant Pharmaceuticals International, Inc. SWOT Analysis
    • 4.5 Allergan plc
      • 4.5.1 Allergan plc Profiles
      • 4.5.2 Allergan plc Product Information
      • 4.5.3 Allergan plc Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Allergan plc SWOT Analysis
    • 4.6 Otsuka Pharmaceutical Co., Ltd.
      • 4.6.1 Otsuka Pharmaceutical Co., Ltd. Profiles
      • 4.6.2 Otsuka Pharmaceutical Co., Ltd. Product Information
      • 4.6.3 Otsuka Pharmaceutical Co., Ltd. Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Otsuka Pharmaceutical Co., Ltd. SWOT Analysis
    • 4.7 Mitotech S.A.
      • 4.7.1 Mitotech S.A. Profiles
      • 4.7.2 Mitotech S.A. Product Information
      • 4.7.3 Mitotech S.A. Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Mitotech S.A. SWOT Analysis
    • 4.8 FCI S.A.S.
      • 4.8.1 FCI S.A.S. Profiles
      • 4.8.2 FCI S.A.S. Product Information
      • 4.8.3 FCI S.A.S. Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 FCI S.A.S. SWOT Analysis
    • 4.9 Shire plc
      • 4.9.1 Shire plc Profiles
      • 4.9.2 Shire plc Product Information
      • 4.9.3 Shire plc Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 Shire plc SWOT Analysis
    • 4.10 Sun Pharmaceutical Industries Ltd.
      • 4.10.1 Sun Pharmaceutical Industries Ltd. Profiles
      • 4.10.2 Sun Pharmaceutical Industries Ltd. Product Information
      • 4.10.3 Sun Pharmaceutical Industries Ltd. Dry Eye DiseaseSales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Sun Pharmaceutical Industries Ltd. SWOT Analysis
    • 4.11 Senju Pharmaceutical Co., Ltd.
    • 4.12 TRB Chemedica International SA
    • 4.13 Sentiss Pharma Pvt. Ltd.
    • 4.14 ...

    5 Market Performance for Manufacturers

    • 5.1 Global Dry Eye Disease Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global Dry Eye Disease Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global Dry Eye Disease Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Dry Eye Disease Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America Dry Eye Disease Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America Dry Eye Disease Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America Dry Eye Disease Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global Dry Eye Disease Market Assessment by Regions (2014-2020)

    • 7.1 Global Dry Eye Disease Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global Dry Eye Disease Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global Dry Eye Disease Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global Dry Eye Disease Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA Dry Eye Disease Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia Dry Eye Disease Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Hospital Pharmacies Industry
    • 11.2 Independent Pharmacies & Drug Stores Industry
    • 11.3 Online pharmacies Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global Dry Eye Disease Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global Dry Eye Disease Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America Dry Eye Disease Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Artificial Tears
      • 12.2.3 Secretagogue
      • 12.2.4 Punctal Plugs
      • 12.2.5 Anti-inflammatory
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospital Pharmacies
      • 12.3.3 Independent Pharmacies & Drug Stores
      • 12.3.4 Online pharmacies
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Dry Eye Disease Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global Dry Eye Disease Gross Profit Trend 2021-2026

    13 Conclusion

    According to XYZResearch study, over the next five years the Dry Eye Diseasemarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Dry Eye Diseasebusiness.
    Dry Eye Disease market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
    Sales forecast by type/application from 2021-2026
    Industry chain, downstream and upstream information is also included.
    World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
    Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
    XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

    This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Dry Eye Disease for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Dry Eye Disease market competition by top manufacturers/players, with Dry Eye Disease sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Santen Pharmaceutical Co., Ltd.
    Novartis AG
    Johnson & Johnson
    Valeant Pharmaceuticals International, Inc.
    Allergan plc
    Otsuka Pharmaceutical Co., Ltd.
    Mitotech S.A.
    FCI S.A.S.
    Shire plc
    Sun Pharmaceutical Industries Ltd.
    Senju Pharmaceutical Co., Ltd.
    TRB Chemedica International SA
    Sentiss Pharma Pvt. Ltd.
    ...
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Artificial Tears
    Secretagogue
    Punctal Plugs
    Anti-inflammatory
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dry Eye Disease for each application, including
    Hospital Pharmacies
    Independent Pharmacies & Drug Stores
    Online pharmacies

    Feel free to let me know if you have any special requirements.

    Buy now